GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » Beta

Cannabis Global (Cannabis Global) Beta : 0.69 (As of May. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-05), Cannabis Global's Beta is 0.69.


Cannabis Global Beta Historical Data

The historical data trend for Cannabis Global's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global Beta Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -2.35 -5.65 -0.89 -0.05

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 -0.05 -0.23 1.24 3.97

Competitive Comparison of Cannabis Global's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's Beta distribution charts can be found below:

* The bar in red indicates where Cannabis Global's Beta falls into.



Cannabis Global Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Cannabis Global  (OTCPK:CBGL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cannabis Global Beta Related Terms

Thank you for viewing the detailed overview of Cannabis Global's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Global (Cannabis Global) Business Description

Traded in Other Exchanges
N/A
Address
520 S. Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Executives
Jim L. Riley director C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc 10 percent owner 0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie director, 10 percent owner 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei director, officer: CEO, CFO 520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc director, 10 percent owner, officer: CEO/President/CFO 1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat 10 percent owner 700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache director, officer: SECRETARY/TREASURER/CFO 3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel director, officer: PRESIDENT/CEO 8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani director 3905 NATIONAL DRIVE, BURTONSVILLE MD 20866